FTO (fat-mass and obesity-associated protein) deficiency aggravates age-dependent depression-like behaviors and cognitive impairment

The demethylase fat mass and obesity-related associated protein (FTO) is strongly associated with depression. Aging is a risk factor for synaptic plasticity damage in the brain and leads to neurocognitive dysfunctions. FTO-dependent m6A modification plays an important role in neurodevelopment and co...

Full description

Saved in:
Bibliographic Details
Published inBehavioral and brain functions Vol. 21; no. 1; p. 18
Main Authors Li, Mengdie, Yang, Yating, Chen, Tangcong, Luo, Yueyang, Zhang, Yingqian, Liu, Huanzhong, Maes, Michael
Format Journal Article
LanguageEnglish
Published England BioMed Central 15.06.2025
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The demethylase fat mass and obesity-related associated protein (FTO) is strongly associated with depression. Aging is a risk factor for synaptic plasticity damage in the brain and leads to neurocognitive dysfunctions. FTO-dependent m6A modification plays an important role in neurodevelopment and cognitive function. However, whether FTO is associated with susceptibility to depression in different age groups remains unknown. We subjected 3-and 12-month-old C57BL/6J male mice to chronic unpredictable mild stress (CUMS) for 6 weeks, of which 3 weeks were used for hippocampal injection of FTO knockdown adeno-associated virus 9 shRNA (FTO-KD AAV9). Finally, 36 male mice in each 3-month-old and 12-month-old groups were divided into three groups (n = 12): Sham, CUMS, and FTO-KD. After 6 weeks, we assessed behavioral deficits (depressive and anxiety-like behaviors and cognitive impairment) by behavioral tests and hippocampal neuronal damage (dendritic spine density, neuronal atrophy, and expression of proteins associated with synaptic plasticity) by molecular biochemical experiments. The results showed that 12-month-old C57BL/6J mice were more likely to develop depression-like behavior and spatial learning and memory impairment induced by CUMS than 3-month-old mice. Chronic stress-induced depression-like behavior and cognitive impairment worsened after the FTO-KD intervention. In the hippocampus of 3- and 12-month-old mice, CUMS induced the downregulation of FTO, nerve growth factor (NGF), reelin, and synaptic plasticity-related proteins. It also caused abnormal brain-derived neurotrophic factor (BDNF)- the tropomyosin-related kinase B (TrkB) signaling, reduced density of dendritic spines, and an increased number of neuronal pyknotic nuclei, leading to neuronal disarray, which was more significant in 12-month-old animals. FTO deficiency accelerated neuronal damage in the hippocampus of 12-month-old CUMS mice. This study provides rodent evidence that FTO deficiency may increase the susceptibility to depression in older adults by impairing hippocampal neuronal function and neuronal synaptic plasticity in an age-dependent manner. This suggests that the development of FTO activators may be an effective treatment for depression in older adults.
AbstractList Abstract Background The demethylase fat mass and obesity-related associated protein (FTO) is strongly associated with depression. Aging is a risk factor for synaptic plasticity damage in the brain and leads to neurocognitive dysfunctions. FTO-dependent m6A modification plays an important role in neurodevelopment and cognitive function. However, whether FTO is associated with susceptibility to depression in different age groups remains unknown. Methods We subjected 3-and 12-month-old C57BL/6J male mice to chronic unpredictable mild stress (CUMS) for 6 weeks, of which 3 weeks were used for hippocampal injection of FTO knockdown adeno-associated virus 9 shRNA (FTO-KD AAV9). Finally, 36 male mice in each 3-month-old and 12-month-old groups were divided into three groups (n = 12): Sham, CUMS, and FTO-KD. After 6 weeks, we assessed behavioral deficits (depressive and anxiety-like behaviors and cognitive impairment) by behavioral tests and hippocampal neuronal damage (dendritic spine density, neuronal atrophy, and expression of proteins associated with synaptic plasticity) by molecular biochemical experiments. Results The results showed that 12-month-old C57BL/6J mice were more likely to develop depression-like behavior and spatial learning and memory impairment induced by CUMS than 3-month-old mice. Chronic stress-induced depression-like behavior and cognitive impairment worsened after the FTO-KD intervention. In the hippocampus of 3- and 12-month-old mice, CUMS induced the downregulation of FTO, nerve growth factor (NGF), reelin, and synaptic plasticity-related proteins. It also caused abnormal brain-derived neurotrophic factor (BDNF)- the tropomyosin-related kinase B (TrkB) signaling, reduced density of dendritic spines, and an increased number of neuronal pyknotic nuclei, leading to neuronal disarray, which was more significant in 12-month-old animals. FTO deficiency accelerated neuronal damage in the hippocampus of 12-month-old CUMS mice. Conclusions This study provides rodent evidence that FTO deficiency may increase the susceptibility to depression in older adults by impairing hippocampal neuronal function and neuronal synaptic plasticity in an age-dependent manner. This suggests that the development of FTO activators may be an effective treatment for depression in older adults.
BackgroundThe demethylase fat mass and obesity-related associated protein (FTO) is strongly associated with depression. Aging is a risk factor for synaptic plasticity damage in the brain and leads to neurocognitive dysfunctions. FTO-dependent m6A modification plays an important role in neurodevelopment and cognitive function. However, whether FTO is associated with susceptibility to depression in different age groups remains unknown.MethodsWe subjected 3-and 12-month-old C57BL/6J male mice to chronic unpredictable mild stress (CUMS) for 6 weeks, of which 3 weeks were used for hippocampal injection of FTO knockdown adeno-associated virus 9 shRNA (FTO-KD AAV9). Finally, 36 male mice in each 3-month-old and 12-month-old groups were divided into three groups (n = 12): Sham, CUMS, and FTO-KD. After 6 weeks, we assessed behavioral deficits (depressive and anxiety-like behaviors and cognitive impairment) by behavioral tests and hippocampal neuronal damage (dendritic spine density, neuronal atrophy, and expression of proteins associated with synaptic plasticity) by molecular biochemical experiments.ResultsThe results showed that 12-month-old C57BL/6J mice were more likely to develop depression-like behavior and spatial learning and memory impairment induced by CUMS than 3-month-old mice. Chronic stress-induced depression-like behavior and cognitive impairment worsened after the FTO-KD intervention. In the hippocampus of 3- and 12-month-old mice, CUMS induced the downregulation of FTO, nerve growth factor (NGF), reelin, and synaptic plasticity-related proteins. It also caused abnormal brain-derived neurotrophic factor (BDNF)- the tropomyosin-related kinase B (TrkB) signaling, reduced density of dendritic spines, and an increased number of neuronal pyknotic nuclei, leading to neuronal disarray, which was more significant in 12-month-old animals. FTO deficiency accelerated neuronal damage in the hippocampus of 12-month-old CUMS mice.ConclusionsThis study provides rodent evidence that FTO deficiency may increase the susceptibility to depression in older adults by impairing hippocampal neuronal function and neuronal synaptic plasticity in an age-dependent manner. This suggests that the development of FTO activators may be an effective treatment for depression in older adults.
The demethylase fat mass and obesity-related associated protein (FTO) is strongly associated with depression. Aging is a risk factor for synaptic plasticity damage in the brain and leads to neurocognitive dysfunctions. FTO-dependent m6A modification plays an important role in neurodevelopment and cognitive function. However, whether FTO is associated with susceptibility to depression in different age groups remains unknown. We subjected 3-and 12-month-old C57BL/6J male mice to chronic unpredictable mild stress (CUMS) for 6 weeks, of which 3 weeks were used for hippocampal injection of FTO knockdown adeno-associated virus 9 shRNA (FTO-KD AAV9). Finally, 36 male mice in each 3-month-old and 12-month-old groups were divided into three groups (n = 12): Sham, CUMS, and FTO-KD. After 6 weeks, we assessed behavioral deficits (depressive and anxiety-like behaviors and cognitive impairment) by behavioral tests and hippocampal neuronal damage (dendritic spine density, neuronal atrophy, and expression of proteins associated with synaptic plasticity) by molecular biochemical experiments. The results showed that 12-month-old C57BL/6J mice were more likely to develop depression-like behavior and spatial learning and memory impairment induced by CUMS than 3-month-old mice. Chronic stress-induced depression-like behavior and cognitive impairment worsened after the FTO-KD intervention. In the hippocampus of 3- and 12-month-old mice, CUMS induced the downregulation of FTO, nerve growth factor (NGF), reelin, and synaptic plasticity-related proteins. It also caused abnormal brain-derived neurotrophic factor (BDNF)- the tropomyosin-related kinase B (TrkB) signaling, reduced density of dendritic spines, and an increased number of neuronal pyknotic nuclei, leading to neuronal disarray, which was more significant in 12-month-old animals. FTO deficiency accelerated neuronal damage in the hippocampus of 12-month-old CUMS mice. This study provides rodent evidence that FTO deficiency may increase the susceptibility to depression in older adults by impairing hippocampal neuronal function and neuronal synaptic plasticity in an age-dependent manner. This suggests that the development of FTO activators may be an effective treatment for depression in older adults.
The demethylase fat mass and obesity-related associated protein (FTO) is strongly associated with depression. Aging is a risk factor for synaptic plasticity damage in the brain and leads to neurocognitive dysfunctions. FTO-dependent m6A modification plays an important role in neurodevelopment and cognitive function. However, whether FTO is associated with susceptibility to depression in different age groups remains unknown.BACKGROUNDThe demethylase fat mass and obesity-related associated protein (FTO) is strongly associated with depression. Aging is a risk factor for synaptic plasticity damage in the brain and leads to neurocognitive dysfunctions. FTO-dependent m6A modification plays an important role in neurodevelopment and cognitive function. However, whether FTO is associated with susceptibility to depression in different age groups remains unknown.We subjected 3-and 12-month-old C57BL/6J male mice to chronic unpredictable mild stress (CUMS) for 6 weeks, of which 3 weeks were used for hippocampal injection of FTO knockdown adeno-associated virus 9 shRNA (FTO-KD AAV9). Finally, 36 male mice in each 3-month-old and 12-month-old groups were divided into three groups (n = 12): Sham, CUMS, and FTO-KD. After 6 weeks, we assessed behavioral deficits (depressive and anxiety-like behaviors and cognitive impairment) by behavioral tests and hippocampal neuronal damage (dendritic spine density, neuronal atrophy, and expression of proteins associated with synaptic plasticity) by molecular biochemical experiments.METHODSWe subjected 3-and 12-month-old C57BL/6J male mice to chronic unpredictable mild stress (CUMS) for 6 weeks, of which 3 weeks were used for hippocampal injection of FTO knockdown adeno-associated virus 9 shRNA (FTO-KD AAV9). Finally, 36 male mice in each 3-month-old and 12-month-old groups were divided into three groups (n = 12): Sham, CUMS, and FTO-KD. After 6 weeks, we assessed behavioral deficits (depressive and anxiety-like behaviors and cognitive impairment) by behavioral tests and hippocampal neuronal damage (dendritic spine density, neuronal atrophy, and expression of proteins associated with synaptic plasticity) by molecular biochemical experiments.The results showed that 12-month-old C57BL/6J mice were more likely to develop depression-like behavior and spatial learning and memory impairment induced by CUMS than 3-month-old mice. Chronic stress-induced depression-like behavior and cognitive impairment worsened after the FTO-KD intervention. In the hippocampus of 3- and 12-month-old mice, CUMS induced the downregulation of FTO, nerve growth factor (NGF), reelin, and synaptic plasticity-related proteins. It also caused abnormal brain-derived neurotrophic factor (BDNF)- the tropomyosin-related kinase B (TrkB) signaling, reduced density of dendritic spines, and an increased number of neuronal pyknotic nuclei, leading to neuronal disarray, which was more significant in 12-month-old animals. FTO deficiency accelerated neuronal damage in the hippocampus of 12-month-old CUMS mice.RESULTSThe results showed that 12-month-old C57BL/6J mice were more likely to develop depression-like behavior and spatial learning and memory impairment induced by CUMS than 3-month-old mice. Chronic stress-induced depression-like behavior and cognitive impairment worsened after the FTO-KD intervention. In the hippocampus of 3- and 12-month-old mice, CUMS induced the downregulation of FTO, nerve growth factor (NGF), reelin, and synaptic plasticity-related proteins. It also caused abnormal brain-derived neurotrophic factor (BDNF)- the tropomyosin-related kinase B (TrkB) signaling, reduced density of dendritic spines, and an increased number of neuronal pyknotic nuclei, leading to neuronal disarray, which was more significant in 12-month-old animals. FTO deficiency accelerated neuronal damage in the hippocampus of 12-month-old CUMS mice.This study provides rodent evidence that FTO deficiency may increase the susceptibility to depression in older adults by impairing hippocampal neuronal function and neuronal synaptic plasticity in an age-dependent manner. This suggests that the development of FTO activators may be an effective treatment for depression in older adults.CONCLUSIONSThis study provides rodent evidence that FTO deficiency may increase the susceptibility to depression in older adults by impairing hippocampal neuronal function and neuronal synaptic plasticity in an age-dependent manner. This suggests that the development of FTO activators may be an effective treatment for depression in older adults.
ArticleNumber 18
Author Chen, Tangcong
Liu, Huanzhong
Yang, Yating
Li, Mengdie
Zhang, Yingqian
Maes, Michael
Luo, Yueyang
Author_xml – sequence: 1
  givenname: Mengdie
  surname: Li
  fullname: Li, Mengdie
– sequence: 2
  givenname: Yating
  surname: Yang
  fullname: Yang, Yating
– sequence: 3
  givenname: Tangcong
  surname: Chen
  fullname: Chen, Tangcong
– sequence: 4
  givenname: Yueyang
  surname: Luo
  fullname: Luo, Yueyang
– sequence: 5
  givenname: Yingqian
  surname: Zhang
  fullname: Zhang, Yingqian
– sequence: 6
  givenname: Huanzhong
  surname: Liu
  fullname: Liu, Huanzhong
– sequence: 7
  givenname: Michael
  surname: Maes
  fullname: Maes, Michael
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40518522$$D View this record in MEDLINE/PubMed
BookMark eNpdkktv1DAQgCNURB_wBzigSFzag8HPxD6hqqKlUqVe9m45zjj1ktjBzq60d344pilVy8ljzzefxvacVkchBqiqjwR_IUQ2XzOhSjGEqUAYU4kRe1OdkJZzpLAkRy_i4-o05y3GTHJK31XHHAsiBaUn1e_rzX197syCJpNzbUJfxw6yXw6o7KP1ZoG-nlNcwIeLugfnrYdgD7UZhmT2JV2qBkA9zBB6CEth5gQ5-xjQ6H9C3cGD2fuYVruNQ_CL30Ptp9n4NJWS99VbZ8YMH57Ws2pz_X1z9QPd3d_cXl3eISsEWRCRrmltSzBXLaVOlVApiQEL5nrLlASujFKcd9wo3uAed9a1HVNN00nasbPqdtX20Wz1nPxk0kFH4_XjQUyDNmnxdgRtFXfSSdECZrxjWPaOdVRQaERbdFBc31bXvOsm6G25RTLjK-nrTPAPeoh7TShpWiGbYjh_MqT4awd50ZPPFsbRBIi7rBklCuOGSlHQz_-h27hLoTxVoWjbcIUJK9Snly099_LvswtAV8CmmHMC94wQrP9OlF4nSpeJ0o8TpRn7AyYnvtY
Cites_doi 10.1016/j.ynstr.2021.100390
10.1016/j.jad.2024.08.088
10.1097/JGP.0b013e31817e739a
10.1016/j.jad.2021.04.037
10.1371/journal.pone.0211937
10.1002/hipo.20653
10.1038/s41467-021-27044-7
10.1073/pnas.95.6.3221
10.1016/j.neulet.2008.06.081
10.1192/bjp.bp.116.183475
10.3389/fimmu.2023.1193053
10.1002/brb3.3356
10.1016/j.exger.2012.04.010
10.1126/science.7907431
10.1007/978-981-33-6044-0_14
10.1016/j.neulet.2022.136918
10.1056/NEJMoa0803839
10.1016/j.ntt.2019.106837
10.1159/000526752
10.1186/s13059-020-02249-z
10.3389/fnagi.2021.697621
10.1177/0253717620981556
10.1155/2023/1474841
10.1038/mp.2017.61
10.1016/j.ejphar.2024.177063
10.1016/j.pbb.2023.173617
10.1016/S0140-6736(18)31948-2
10.3390/nu6083130
10.1016/j.brs.2018.04.003
10.1371/journal.pone.0014005
10.1016/j.neubiorev.2018.12.002
10.1001/archgenpsychiatry.2010.2
10.1016/j.bbr.2023.114598
10.1113/EP089415
10.1016/j.euroneuro.2022.02.003
10.1523/JNEUROSCI.4053-15.2016
10.1093/hmg/ddx128
10.1016/j.ajhg.2009.06.002
10.1016/j.cell.2012.05.003
10.1016/j.psychres.2023.115402
10.1080/00207454.2018.1527328
10.1177/0271678X20960033
10.3389/fncel.2022.884296
10.1007/s11010-023-04719-x
10.1016/j.jad.2023.05.069
10.1016/j.neuron.2018.07.009
10.1093/nar/gkx1182
10.1016/j.physbeh.2022.113971
10.1038/nrn1726
10.1016/j.physbeh.2020.113236
10.1161/STROKEAHA.122.040401
10.1146/annurev-neuro-072116-031357
10.3390/ijms24076220
10.1016/j.npep.2024.102428
10.1097/01.JGP.0000203130.45421.69
10.1016/j.neuroscience.2013.06.050
10.1155/2022/2677312
10.1017/S0033291713002535
10.1126/science.1074952
10.1186/s12864-016-2913-x
10.1093/hmg/ddaa171
10.7150/thno.31562
10.1093/hmg/ddu043
10.1016/j.jhazmat.2024.134969
10.1080/17446651.2021.1889367
10.1038/npp.2017.31
10.1523/JNEUROSCI.17-01-00023.1997
10.1038/nn.3449
ContentType Journal Article
Copyright 2025. The Author(s).
2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2025 2025
Copyright_xml – notice: 2025. The Author(s).
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2025 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QG
7TK
7X7
7XB
88E
88G
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
K9.
M0S
M1P
M2M
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOA
DOI 10.1186/s12993-025-00280-3
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Animal Behavior Abstracts
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Proquest Central
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Psychology Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
Animal Behavior Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Psychology
EISSN 1744-9081
EndPage 18
ExternalDocumentID oai_doaj_org_article_c94f8f857e034b308df3b252e657966e
PMC12167586
40518522
10_1186_s12993_025_00280_3
Genre Journal Article
GeographicLocations China
Shenzhen China
GeographicLocations_xml – name: Shenzhen China
– name: China
GrantInformation_xml – fundername: Research Fund of Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital
  grantid: NO.24QNPY019
GroupedDBID ---
0R~
23N
2WC
53G
5GY
5VS
6J9
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABIVO
ABUWG
ACGFO
ACGFS
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
AZQEC
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
DWQXO
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
IPY
ISR
ITC
KQ8
M1P
M2M
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PSYQQ
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
WOQ
WOW
XSB
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
3V.
7QG
7TK
7XB
8FK
K9.
M48
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c551t-18f67c71049722f9c719980e053fdc398e49a9944b4a9460d0bcf7b3966b82b3
IEDL.DBID 7X7
ISSN 1744-9081
IngestDate Wed Aug 27 01:29:13 EDT 2025
Thu Aug 21 18:27:52 EDT 2025
Fri Jul 11 17:05:01 EDT 2025
Sat Aug 23 12:29:53 EDT 2025
Mon Jul 21 06:04:23 EDT 2025
Thu Jul 03 08:23:38 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords FTO
BDNF-TrkB signaling pathway
Chronic unpredictable mild stress (CUMS)
Synaptic plasticity
Cognitive impairment
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c551t-18f67c71049722f9c719980e053fdc398e49a9944b4a9460d0bcf7b3966b82b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/3227649013?pq-origsite=%requestingapplication%
PMID 40518522
PQID 3227649013
PQPubID 55045
ParticipantIDs doaj_primary_oai_doaj_org_article_c94f8f857e034b308df3b252e657966e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12167586
proquest_miscellaneous_3219006285
proquest_journals_3227649013
pubmed_primary_40518522
crossref_primary_10_1186_s12993_025_00280_3
PublicationCentury 2000
PublicationDate 2025-06-15
PublicationDateYYYYMMDD 2025-06-15
PublicationDate_xml – month: 06
  year: 2025
  text: 2025-06-15
  day: 15
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Behavioral and brain functions
PublicationTitleAlternate Behav Brain Funct
PublicationYear 2025
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References AC Mondal (280_CR10) 2019; 129
BJ Walters (280_CR66) 2017; 42
C Yang (280_CR31) 2021; 229
MI Afridi (280_CR1) 2011; 21
KD Meyer (280_CR18) 2012; 149
Y Wen (280_CR20) 2024; 476
A Martinez-Pinteno (280_CR11) 2022; 57
TJ Story (280_CR2) 2008; 16
Y Tu (280_CR59) 2024; 14
A Bachis (280_CR37) 2008; 442
GS Malhi (280_CR4) 2018; 392
AA Loch (280_CR12) 2023; 327
J Yu (280_CR21) 2018; 46
Y Jiang (280_CR40) 2023; 453
S Liu (280_CR46) 2021; 12
M Engel (280_CR45) 2018; 99
L Sun (280_CR53) 2019; 9
C Pesold (280_CR13) 1998; 95
JE Cecil (280_CR35) 2008; 359
ME Hess (280_CR22) 2013; 16
M Mehrdad (280_CR49) 2021; 16
AK Chokkalla (280_CR70) 2023; 54
S Yanai (280_CR47) 2021; 13
A Spychala (280_CR44) 2019; 14
J Harbron (280_CR51) 2014; 6
F Liu (280_CR63) 2024; 984
AK Chokkalla (280_CR24) 2020; 40
S Boissel (280_CR26) 2009; 85
R Takaba (280_CR32) 2022; 257
A Ghosh (280_CR9) 1994; 263
FS Luppino (280_CR67) 2010; 67
D Ibi (280_CR16) 2023; 230
280_CR43
KR Maynard (280_CR57) 2018; 11
R Chang (280_CR54) 2022; 2022
J Widagdo (280_CR65) 2016; 36
RK Bhalla (280_CR5) 2006; 14
H Mitsuhashi (280_CR23) 2023
PF Wu (280_CR52) 2021; 15
X Fan (280_CR7) 2017; 40
F Hu (280_CR36) 2023; 113
AM Shafik (280_CR19) 2021; 22
B Pan (280_CR34) 2022; 791
E Malatynska (280_CR39) 2012; 47
M Amidfar (280_CR62) 2021; 1305
L Li (280_CR48) 2017; 26
E Castren (280_CR58) 2017; 22
X Song (280_CR29) 2021; 290
Z Xu (280_CR42) 2024; 479
X Xu (280_CR55) 2024; 365
Y Wang (280_CR69) 2024; 105
G D’Arcangelo (280_CR14) 1997; 17
P Li (280_CR61) 2023; 2023
H Gao (280_CR64) 2020; 29
D Ibi (280_CR30) 2019; 76
SSR Mukku (280_CR6) 2021; 43
L Lin (280_CR68) 2014; 23
X Gao (280_CR25) 2010; 5
S Antoniuk (280_CR28) 2019; 99
C Zhuo (280_CR33) 2023; 337
NM Fournier (280_CR15) 2010; 20
PL Rock (280_CR3) 2014; 44
S Morcuende (280_CR60) 2013; 250
B Lu (280_CR8) 2005; 6
S Fang (280_CR56) 2023; 14
GH Patterson (280_CR27) 2002; 297
A Ghaffari-Nasab (280_CR38) 2021; 106
XL Wang (280_CR41) 2022; 16
M Rivera (280_CR50) 2017; 211
X Cui (280_CR17) 2016; 17
References_xml – volume: 15
  start-page: 100390
  year: 2021
  ident: 280_CR52
  publication-title: Neurobiol Stress
  doi: 10.1016/j.ynstr.2021.100390
– volume: 365
  start-page: 213
  year: 2024
  ident: 280_CR55
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2024.08.088
– volume: 16
  start-page: 752
  issue: 9
  year: 2008
  ident: 280_CR2
  publication-title: Am J Geriatr Psychiatry
  doi: 10.1097/JGP.0b013e31817e739a
– volume: 290
  start-page: 353
  year: 2021
  ident: 280_CR29
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2021.04.037
– volume: 14
  start-page: e0211937
  issue: 2
  year: 2019
  ident: 280_CR44
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0211937
– volume: 20
  start-page: 659
  issue: 5
  year: 2010
  ident: 280_CR15
  publication-title: Hippocampus
  doi: 10.1002/hipo.20653
– volume: 12
  start-page: 6937
  issue: 1
  year: 2021
  ident: 280_CR46
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-27044-7
– volume: 95
  start-page: 3221
  issue: 6
  year: 1998
  ident: 280_CR13
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.95.6.3221
– volume: 442
  start-page: 104
  issue: 2
  year: 2008
  ident: 280_CR37
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2008.06.081
– volume: 211
  start-page: 70
  issue: 2
  year: 2017
  ident: 280_CR50
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.bp.116.183475
– volume: 14
  start-page: 1193053
  year: 2023
  ident: 280_CR56
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2023.1193053
– volume: 14
  start-page: e3356
  issue: 1
  year: 2024
  ident: 280_CR59
  publication-title: Brain Behav
  doi: 10.1002/brb3.3356
– volume: 47
  start-page: 552
  issue: 8
  year: 2012
  ident: 280_CR39
  publication-title: Exp Gerontol
  doi: 10.1016/j.exger.2012.04.010
– volume: 263
  start-page: 1618
  issue: 5153
  year: 1994
  ident: 280_CR9
  publication-title: Science
  doi: 10.1126/science.7907431
– volume: 1305
  start-page: 257
  year: 2021
  ident: 280_CR62
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-981-33-6044-0_14
– volume: 791
  start-page: 136918
  year: 2022
  ident: 280_CR34
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2022.136918
– volume: 359
  start-page: 2558
  issue: 24
  year: 2008
  ident: 280_CR35
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0803839
– volume: 76
  start-page: 106837
  year: 2019
  ident: 280_CR30
  publication-title: Neurotoxicol Teratol
  doi: 10.1016/j.ntt.2019.106837
– volume: 113
  start-page: 80
  issue: 1
  year: 2023
  ident: 280_CR36
  publication-title: Neuroendocrinology
  doi: 10.1159/000526752
– volume: 22
  start-page: 17
  issue: 1
  year: 2021
  ident: 280_CR19
  publication-title: Genome Biol
  doi: 10.1186/s13059-020-02249-z
– volume: 13
  start-page: 697621
  year: 2021
  ident: 280_CR47
  publication-title: Front Aging Neurosci
  doi: 10.3389/fnagi.2021.697621
– volume: 43
  start-page: 286
  issue: 4
  year: 2021
  ident: 280_CR6
  publication-title: Indian J Psychol Med
  doi: 10.1177/0253717620981556
– volume: 2023
  start-page: 1474841
  year: 2023
  ident: 280_CR61
  publication-title: Neural Plast
  doi: 10.1155/2023/1474841
– volume: 22
  start-page: 1085
  issue: 8
  year: 2017
  ident: 280_CR58
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2017.61
– volume: 984
  start-page: 177063
  year: 2024
  ident: 280_CR63
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2024.177063
– volume: 230
  start-page: 173617
  year: 2023
  ident: 280_CR16
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/j.pbb.2023.173617
– ident: 280_CR43
– volume: 392
  start-page: 2299
  issue: 10161
  year: 2018
  ident: 280_CR4
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)31948-2
– volume: 6
  start-page: 3130
  issue: 8
  year: 2014
  ident: 280_CR51
  publication-title: Nutrients
  doi: 10.3390/nu6083130
– volume: 11
  start-page: 856
  issue: 4
  year: 2018
  ident: 280_CR57
  publication-title: Brain Stimul
  doi: 10.1016/j.brs.2018.04.003
– volume: 5
  start-page: e14005
  issue: 11
  year: 2010
  ident: 280_CR25
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0014005
– volume: 99
  start-page: 101
  year: 2019
  ident: 280_CR28
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2018.12.002
– volume: 67
  start-page: 220
  issue: 3
  year: 2010
  ident: 280_CR67
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2010.2
– volume: 453
  start-page: 114598
  year: 2023
  ident: 280_CR40
  publication-title: Behav Brain Res
  doi: 10.1016/j.bbr.2023.114598
– volume: 106
  start-page: 1621
  issue: 7
  year: 2021
  ident: 280_CR38
  publication-title: Exp Physiol
  doi: 10.1113/EP089415
– volume: 57
  start-page: 105
  year: 2022
  ident: 280_CR11
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2022.02.003
– volume: 36
  start-page: 6771
  issue: 25
  year: 2016
  ident: 280_CR65
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.4053-15.2016
– volume: 21
  start-page: 351
  issue: 6
  year: 2011
  ident: 280_CR1
  publication-title: J Coll Physicians Surg Pak
– volume: 26
  start-page: 2398
  issue: 13
  year: 2017
  ident: 280_CR48
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddx128
– volume: 85
  start-page: 106
  issue: 1
  year: 2009
  ident: 280_CR26
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2009.06.002
– volume: 149
  start-page: 1635
  issue: 7
  year: 2012
  ident: 280_CR18
  publication-title: Cell
  doi: 10.1016/j.cell.2012.05.003
– volume: 327
  start-page: 115402
  year: 2023
  ident: 280_CR12
  publication-title: Psychiatry Res
  doi: 10.1016/j.psychres.2023.115402
– volume: 129
  start-page: 283
  issue: 3
  year: 2019
  ident: 280_CR10
  publication-title: Int J Neurosci
  doi: 10.1080/00207454.2018.1527328
– volume: 40
  start-page: 2331
  issue: 12
  year: 2020
  ident: 280_CR24
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1177/0271678X20960033
– volume: 16
  start-page: 884296
  year: 2022
  ident: 280_CR41
  publication-title: Front Cell Neurosci
  doi: 10.3389/fncel.2022.884296
– volume: 479
  start-page: 325
  issue: 2
  year: 2024
  ident: 280_CR42
  publication-title: Mol Cell Biochem
  doi: 10.1007/s11010-023-04719-x
– volume: 337
  start-page: 128
  year: 2023
  ident: 280_CR33
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2023.05.069
– volume: 99
  start-page: 389
  issue: 2
  year: 2018
  ident: 280_CR45
  publication-title: Neuron
  doi: 10.1016/j.neuron.2018.07.009
– volume: 46
  start-page: 1412
  issue: 3
  year: 2018
  ident: 280_CR21
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkx1182
– volume: 257
  start-page: 113971
  year: 2022
  ident: 280_CR32
  publication-title: Physiol Behav
  doi: 10.1016/j.physbeh.2022.113971
– volume: 6
  start-page: 603
  issue: 8
  year: 2005
  ident: 280_CR8
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn1726
– volume: 229
  start-page: 113236
  year: 2021
  ident: 280_CR31
  publication-title: Physiol Behav
  doi: 10.1016/j.physbeh.2020.113236
– volume: 54
  start-page: 245
  issue: 1
  year: 2023
  ident: 280_CR70
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.122.040401
– volume: 40
  start-page: 251
  year: 2017
  ident: 280_CR7
  publication-title: Annu Rev Neurosci
  doi: 10.1146/annurev-neuro-072116-031357
– year: 2023
  ident: 280_CR23
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms24076220
– volume: 105
  start-page: 102428
  year: 2024
  ident: 280_CR69
  publication-title: Neuropeptides
  doi: 10.1016/j.npep.2024.102428
– volume: 14
  start-page: 419
  issue: 5
  year: 2006
  ident: 280_CR5
  publication-title: Am J Geriatr Psychiatry
  doi: 10.1097/01.JGP.0000203130.45421.69
– volume: 250
  start-page: 31
  year: 2013
  ident: 280_CR60
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2013.06.050
– volume: 2022
  start-page: 2677312
  year: 2022
  ident: 280_CR54
  publication-title: Biomed Res Int
  doi: 10.1155/2022/2677312
– volume: 44
  start-page: 2029
  issue: 10
  year: 2014
  ident: 280_CR3
  publication-title: Psychol Med
  doi: 10.1017/S0033291713002535
– volume: 297
  start-page: 1873
  issue: 5588
  year: 2002
  ident: 280_CR27
  publication-title: Science
  doi: 10.1126/science.1074952
– volume: 17
  start-page: 520
  issue: Suppl 7
  year: 2016
  ident: 280_CR17
  publication-title: BMC Genomics
  doi: 10.1186/s12864-016-2913-x
– volume: 29
  start-page: 2775
  issue: 16
  year: 2020
  ident: 280_CR64
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddaa171
– volume: 9
  start-page: 721
  issue: 3
  year: 2019
  ident: 280_CR53
  publication-title: Theranostics
  doi: 10.7150/thno.31562
– volume: 23
  start-page: 3299
  issue: 12
  year: 2014
  ident: 280_CR68
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddu043
– volume: 476
  start-page: 134969
  year: 2024
  ident: 280_CR20
  publication-title: J Hazard Mater
  doi: 10.1016/j.jhazmat.2024.134969
– volume: 16
  start-page: 87
  issue: 2
  year: 2021
  ident: 280_CR49
  publication-title: Expert Rev Endocrinol Metab
  doi: 10.1080/17446651.2021.1889367
– volume: 42
  start-page: 1502
  issue: 7
  year: 2017
  ident: 280_CR66
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2017.31
– volume: 17
  start-page: 23
  issue: 1
  year: 1997
  ident: 280_CR14
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.17-01-00023.1997
– volume: 16
  start-page: 1042
  issue: 8
  year: 2013
  ident: 280_CR22
  publication-title: Nat Neurosci
  doi: 10.1038/nn.3449
SSID ssj0038422
Score 2.3889031
Snippet The demethylase fat mass and obesity-related associated protein (FTO) is strongly associated with depression. Aging is a risk factor for synaptic plasticity...
BackgroundThe demethylase fat mass and obesity-related associated protein (FTO) is strongly associated with depression. Aging is a risk factor for synaptic...
Abstract Background The demethylase fat mass and obesity-related associated protein (FTO) is strongly associated with depression. Aging is a risk factor for...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 18
SubjectTerms Age
Aging
Aging - metabolism
Alpha-Ketoglutarate-Dependent Dioxygenase FTO - deficiency
Alpha-Ketoglutarate-Dependent Dioxygenase FTO - genetics
Alpha-Ketoglutarate-Dependent Dioxygenase FTO - metabolism
Animal cognition
Animals
Anxiety
Anxiety - metabolism
Atrophy
BDNF-TrkB signaling pathway
Behavior
Behavior, Animal - physiology
Body fat
Brain injury
Brain research
Brain-derived neurotrophic factor
Brain-Derived Neurotrophic Factor - metabolism
Chronic unpredictable mild stress (CUMS)
Cognition
Cognitive ability
Cognitive Dysfunction - genetics
Cognitive Dysfunction - metabolism
Cognitive impairment
Dendritic spines
Dendritic Spines - metabolism
Depression - genetics
Depression - metabolism
FTO
Hippocampus
Hippocampus - metabolism
Hippocampus - pathology
Kinases
Light
Male
Mental depression
Mice
Mice, Inbred C57BL
N6-methyladenosine
Nerve growth factor
Neurogenesis
Neuronal Plasticity - physiology
Neurons - metabolism
Neuroplasticity
Obesity
Protein deficiency
Proteins
Reelin Protein
Risk factors
Spatial discrimination learning
Spatial memory
Stress, Psychological - metabolism
Sucrose
Surgery
Synaptic plasticity
TrkB receptors
Tropomyosin
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxQxFA_Sg_QiuvVjtEoEEUVCZ5JMJjlWcSlC9bJCbyGfuqhZabeH3vuH9yWZGboiePEWZpKZzLyX934veR8IvepaQwEpexIHHwmPwRFlgZf7IYAydNKFEi52-lmcfOWfzvqzW6W-sk9YTQ9cf9yRUzzKKGFsy7hlrfSRWdrTIHIUpQhZ-oLOm4ypKoOZ5JROITJSHF2AVst-arQn5SyRsB01VLL1_w1i_ukpeUv1LO-jeyNmxMd1rg_QnZAW6OA4gb386wq_xsWLs2yPL9Dd0_GwfIH2Z-F2dYCul6sv-E00YOYCXMYmebypNQGIGSkUPC5ZG9bpLfYhZ5bIYZnYfMslijIkhWYgU9XcLZ6daBP5uf4R8BTxX58--yXhHIi5Ps-7kA_Ravlx9eGEjBUYiAMktSWdjGJwAEK4GiiNCppgnrW5nET0jikZuDJKcW65UVy0vrUuDpYBYayklj1Ce2mTwhOEFe-i7a2nsXPcMwEjrQnRWMAIwpu-Qe8meujfNc-GLvaJFLpSTwP1dKGeZg16n0k298w5sssF4Bw9co7-F-c06HAiuB4X7oUG-TYIDiAJ3vFyvg1LLp-jmBQ2l7kPoKgSe9qgx5U_5pkA_s3h6LRBcodzdqa6eyetv5e03h3tsvUmnv6Pj3uG9mlhd0G6_hDtbc8vw3OAT1v7oqyUG14EGVw
  priority: 102
  providerName: Directory of Open Access Journals
Title FTO (fat-mass and obesity-associated protein) deficiency aggravates age-dependent depression-like behaviors and cognitive impairment
URI https://www.ncbi.nlm.nih.gov/pubmed/40518522
https://www.proquest.com/docview/3227649013
https://www.proquest.com/docview/3219006285
https://pubmed.ncbi.nlm.nih.gov/PMC12167586
https://doaj.org/article/c94f8f857e034b308df3b252e657966e
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NaxQxFH9oC9JL0a0fo3WJIKJI6EySyWRO0pUuRWiVssLiZUgmSV20s3V3e-jdP9yXzIeuiJchTDJD4L3k_d43wMss1QyRsqW-sJ4K72paGuTlvHAoDGtVu5gudnYuTz-LD_N83hnc1l1YZX8nxovaLutgIz9CxiukQOnF313_oKFrVPCudi007sJuKF0WuLqYDwoXV4KxPlFGyaM1yrYQrcZyGj2KlG8Jo1iz_19A8-94yT8E0PQ-7HfIkRy3pH4Ad1wzgoPjBrXmq1vyisRYzmgkH8G9s85lPoK94Yq7PYCf09lH8tprVHYRNBPdWLJsOwNQ3dHJWRJrNyyaN8S6UF8iJGcSfRkaFQVgikNH-965GzKE0jb0--KbI33ef_v3ITqJhHTMxSrYIh_CbHoye39Kuz4MtEY8taGZ8rKoEYqIsmDMlzhEJS0NTSW8rXmpnCh1WQphhC6FTG1qal8YjpqUUczwR7DTLBv3BEgpMm9yY5nPamG5xC-Ndl4bRArS6jyBtz09quu22kYVtRQlq5Z6FVKvitSreAKTQLJhZaiUHV8sV5dVd_CquhReeYW8l3JheKqs54blzMmQhStdAoc9wavu-K6r38yWwIthGg9e8Kboxi1vwhrEUjEDNYHHLX8MO0EUHJLSWQJqi3O2tro90yy-xuLeGcuCDief_n9fz2CPRUaWNMsPYWezunHPER5tzDiegTHsTk7OP12Mo5EBnxeTL78AzN4U7A
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD4aQ4K9IOi4BAYYCRAIWUtsx0keEBqXqmPreClS36w4tkcFpKPthPrO3-E_cuxcoAjxtrcoN1k6n32-zz4XgMdJXDJkyoa6zDgqnK1ooRHLaWbRGVZ5ZUO62PhEjj6K99N0ugU_u1wYH1bZrYlhoTbzyu-R7yPwMinQe_FXZ9-o7xrlT1e7FhoNLI7s-jtKtuXLw7do3yeMDd9N3oxo21WAVsgOVjTJncwqdKyiyBhzBV6i5Ih9iwRnKl7kVhRlUQihRVkIGZtYVy7THHWBzpnm-NtLcBn9buy1Xjbt9R3PBWNdXk4u95foSn1wHEtpOMCkfMP3hRYB_-K1f4dn_uHvhtfhWktUyUGDrBuwZesB7B7UKNK_rslTEkJHw578AK6M2xP6Aez0K-p6F34MJx_IM1eitkaOTsrakHnTiICWLSysIaFUxKx-Toz15Sx8LigpT31fJM-D8dLSrlXvivSRuzX9MvtsSVdmoPl7HwxFfPbnbOG3Pm_C5CIMdAu263lt7wApROJ0qg1zSSUMl_ilLq0rNRITaco0ghedPdRZU9xDBVGUS9VYT6H1VLCe4hG89ibr3_SFucON-eJUtfNcVYVwucsR6jEXmse5cVyzlFnpk36ljWCvM7hqV4ul-o3tCB71j3Ge-8Obsrbzc_8OUreQ8BrB7QYf_UiQdPsceBZBvoGcjaFuPqlnn0It8YQlXjLKu_8f10O4OpqMj9Xx4cnRPdhhAdSSJukebK8W5_Y-MrOVfhDmAwF1wfPvF2YcS-s
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=FTO+%28fat-mass+and+obesity-associated+protein%29+deficiency+aggravates+age-dependent+depression-like+behaviors+and+cognitive+impairment&rft.jtitle=Behavioral+and+brain+functions&rft.au=Li%2C+Mengdie&rft.au=Yang%2C+Yating&rft.au=Chen%2C+Tangcong&rft.au=Luo%2C+Yueyang&rft.date=2025-06-15&rft.eissn=1744-9081&rft.volume=21&rft.issue=1&rft.spage=18&rft_id=info:doi/10.1186%2Fs12993-025-00280-3&rft_id=info%3Apmid%2F40518522&rft.externalDocID=40518522
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1744-9081&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1744-9081&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1744-9081&client=summon